Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF561 antisense RNA 1 is a long non-coding RNA located on human chromosome 19p13.2. It does not encode a protein, but regulates gene expression post-transcriptionally. In colorectal cancer, ZNF561-AS1 is overexpressed and acts as an oncogenic factor by sequestering miR-26a-5p and miR-128-3p, thereby promoting the upregulation of SRSF6, a serine-arginine-rich splicing factor. This stimulates cell proliferation, supports cell cycle progression, and suppresses apoptosis in cancer cells. ZNF561-AS1 may have tissue-specific roles, functioning as a tumor promoter in some contexts and a suppressor in others. No direct pharmacological agents currently target ZNF561-AS1, but its expression level is being explored as a biomarker and its inhibition represents a potential therapeutic strategy for cancers exhibiting dysregulation of this lncRNA
Inhibition of lncRNA-mediated miRNA sponging, suppressing downstream oncogenic pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF561 antisense RNA 1 (ZNF561-AS1).